OVA-Q7 Peptide, pQ7, SIINFEQL, OVA (257-264) Variant is a modified ovalbumin epitope used to probe MHC anchor residue tolerance. Substitution at the C-terminal position fine-tunes peptide–MHC stability and TCR engagement. Researchers employ it to dissect subtle sequence effects on antigen potency. The peptide aids comparative immunological profiling against canonical SIINFEKL.
CAT No: O05023
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More